Aerosol deposition in the human lung periphery is increased by reduced-density gas breathing.
Aerosol mixing resulting from turbulent flows is thought to be a major mechanism of deposition in the upper respiratory tract (URT). Because turbulence levels are a function of gas density, the use of a low-density carrier gas should reduce deposition in the URT allowing the aerosol to reach more peripheral airways of the lung. We performed aerosol bolus tests on 11 healthy subjects to investigate the effect of reduced gas density on regional aerosol deposition in the human lung. Using both air and heliox (80% helium, 20% oxygen) as carrier gas, boluses of 1 and 2 microm-diameter particles were inhaled to five volumetric lung depths (V(p)) between 150 and 1200 mL during an inspiration from residual volume (RV) to 1 liter above functional residual capacity at a constant flow rate of approximately 0.50 L/sec, which was immediately followed by an expiration to RV at the same flow rate. Aerosol deposition and axial dispersion were calculated from aerosol concentration and flow rate measured at the mouth. For 1 microm-diameter particles, deposition was significantly reduced by 29 +/- 28% (mean +/- SD, p < 0.05) when breathing heliox instead of air at shallow V(p) (150 mL) and significantly increased by 11 +/- 9% at deep V(p) (1200 mL). For 2 microm-diameter particles, deposition was significantly higher at V(p) = 500 mL by 6 +/- 7% and the predicted V(p) to achieve 100% deposition was significantly lower with heliox (834 +/- 146 mL) compared to air (912 +/- 128 mL) (p < 0.05). Despite a decrease in deposition at shallow V(p), there was no change in axial dispersion, suggesting that other factors such as radial turbulent mixing result in decreased aerosol deposition. Our results suggested that heliox reduces upper airway deposition of 1 and 2 microm-diameter particles allowing more particles to penetrate and subsequently deposit in the peripheral lung.
Department of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Jonathan B
JB
Peterson
G Kim
GK
Prisk
Chantal
C
Darquenne
D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D006371:Helium / Q000008:administration & dosage*; D006801:Humans; D008168:Lung / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000008:administration & dosage*; D010316:Particle Size; D014018:Tissue Distribution
D000336:Aerosols; D006371:Helium; C038949:heliox; D010100:Oxygen